Search

Your search keyword '"Hodge, Alex"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Hodge, Alex" Remove constraint Author: "Hodge, Alex"
44 results on '"Hodge, Alex"'

Search Results

1. SAT-464-YI Transaminases and older adults: distribution and associations with all-cause mortality

3. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

10. Reverse Phase Protein Microarrays

11. An exploratory study examining how nano-liquid chromatography–mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease

13. Additional file 1 of Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells

17. Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis

18. Additional file 1: of An exploratory study examining how nano-liquid chromatography–mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease

19. Phosphoproteomic Analysis Identifies Dynamic Regulation of Caveolin‐1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells

20. Pathway Analysis of Serum Analytes and Phosphorylated Proteins and their Involvement in Regulatory Pathways in Patients with Non-Alcoholic Steatohepatitis (NASH)

21. Association of Serum and Liver Proteomic Profiling of Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Reveals Common Pathways Linking Non-Alcoholic Steatohepatitis (NASH) and Metabolic Abnormalities

22. The Molecular Crosstalk Between Hepatic Tissue and Visceral Adipose Tissue in Patients with Obesity-Related Nonalcoholic Fatty Liver Disease (NAFLD): The Interactions between Inflammation and Immune Activation

24. MA04.06 Signaling Networks in KRAS-Mutant Advanced NSCLC: A Complex Landscape Involving Immunoresponse, Inflammation and DNA Repair

25. Mo1372 - The Molecular Crosstalk Between Hepatic Tissue and Visceral Adipose Tissue in Patients with Obesity-Related Nonalcoholic Fatty Liver Disease (NAFLD): The Interactions between Inflammation and Immune Activation

26. Sa1563 - Association of Serum and Liver Proteomic Profiling of Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Reveals Common Pathways Linking Non-Alcoholic Steatohepatitis (NASH) and Metabolic Abnormalities

27. 747 - Pathway Analysis of Serum Analytes and Phosphorylated Proteins and their Involvement in Regulatory Pathways in Patients with Non-Alcoholic Steatohepatitis (NASH)

35. Pervasive Aniconism: A Cognitive Approach to Elagabal’s Sacred Stone of Emesa

36. An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease.

37. Abstinence debate. (Letters)

38. COVID-19 vaccinations in patients with chronic liver disease - experience of a tertiary centre in Melbourne.

39. FRI214 - Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis.

40. Reverse Phase Protein Microarrays.

41. Antibody Validation by Western Blotting.

42. Pacemaker interactions induce reentrant wave dynamics in engineered cardiac culture.

43. Chaotic dynamics in cardiac aggregates induced by potassium channel block.

44. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Catalog

Books, media, physical & digital resources